{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:30:35Z","timestamp":1740148235646,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12094-020-02510-8","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T13:03:04Z","timestamp":1606309384000},"page":"1193-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Consensus and recommendations on vaginal-cuff Brachytherapy of the Spanish Brachytherapy Groups of SEOR and SEFM"],"prefix":"10.1007","volume":"23","author":[{"name":"the SEOR and the SEFM Brachytherapy Groups","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-6431","authenticated-orcid":false,"given":"P. M.","family":"Samper Ots","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7832-334X","authenticated-orcid":false,"given":"A.","family":"Rovirosa Casino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-481X","authenticated-orcid":false,"given":"A.","family":"Herreros Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Rodriguez Villalba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"P\u00e9rez Calatayud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Polo Cez\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Guti\u00e9rrez Migu\u00e9lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Anchuelo Latorre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Rodr\u00edguez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"C\u00f3rdoba Largo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"P\u00e9rez Echag\u00fcen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. J.","family":"Sanz Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Clemente Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"De las Pe\u00f1as Cabrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Villafranca Iturre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"issue":"8","key":"2510_CR1","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/ijc.31937","volume":"144","author":"J Ferlay","year":"2019","unstructured":"Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941\u201353. https:\/\/doi.org\/10.1002\/ijc.31937.","journal-title":"Int J Cancer"},{"key":"2510_CR2","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12094-012-0794-2","volume":"14","author":"JL Guinot","year":"2012","unstructured":"Guinot JL, P\u00e9rez-Calatayud J, Azcoaga JM, Herruzo I, Bodineau C, Rovirosa A, Crisp\u00edn V, Gal\u00e1n P, Gonz\u00e1lez-Pati\u00f1o E, P\u00e9rez-Regadera J, Polo A, on behalf of the SEOR and the SEFM Brachytherapy Groups. Consensus on treatment of endometrium carcinoma with brachytherapy. Clin Transl Oncol. 2012;14:263\u201370.","journal-title":"Clin Transl Oncol"},{"key":"2510_CR3","volume-title":"The GEC ESTRO handbook of brachytherapy","author":"P Hoskin","year":"2016","unstructured":"Hoskin P, Hellebust TP, Nout R, J\u03c5\u0308rgenliemk-Schulz I, Meder CH, Van Limbergen E, Poetter R. Endometrial cancer. In: Van Limbergen E, P\u00f6tter R, Hoskin P, Baltas D, editors. The GEC ESTRO handbook of brachytherapy. Belgium: ESTRO; 2016."},{"key":"2510_CR4","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2020","unstructured":"Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomized trial. Lancet. 2020;375:816\u201323.","journal-title":"Lancet"},{"key":"2510_CR5","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/S0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC study group. Postoperative radiation therapy in endometrial carcinoma. Lancet. 2000;355:1404\u201311.","journal-title":"Lancet"},{"key":"2510_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys HM, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study. Gynecol Oncol. 2004;92:744\u201351.","journal-title":"Gynecol Oncol"},{"issue":"13","key":"2510_CR7","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1200\/JCO.2010.32.4590","volume":"29","author":"RA Nout","year":"2011","unstructured":"Nout RA, van de Poll-Franse LV, Lybeert ML, et al. Long-term outcome and quality of life of patients with endometrial carcinoma treated with or without pelvic radiotherapy in the postoperative radiation therapy in endometrial carcinoma 1 (PORTEC-1) trial. J Clin Oncol. 2011;29(13):1692\u2013700. https:\/\/doi.org\/10.1200\/JCO.2010.32.4590.","journal-title":"J Clin Oncol"},{"issue":"9","key":"2510_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","volume":"119","author":"BG Wortman","year":"2018","unstructured":"Wortman BG, Creutzberg CL, Putter H, et al. Ten-year results of the PORTEC-2 trial for high intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. Br J Cancer. 2018;119(9):1067\u201374. https:\/\/doi.org\/10.1038\/s41416-018-0310-8.","journal-title":"Br J Cancer"},{"key":"2510_CR9","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","volume":"4","author":"A Klopp","year":"2014","unstructured":"Klopp A, Smith BD, Alektiar K, Cabrera A, Damato AL, Erickson B, Fleming G, Gaffney D, Greven K, Lu K, Miller D, Moore D, Petereit D, Schefter T, Small W Jr, Yashar C, Viswanathan AN. The role of postoperative radiation therapy for endometrial cancer: executive summary of an American Society for Radiation Oncology evidence-based guideline. Pract Radiat Oncol. 2014;4:137\u201344.","journal-title":"Pract Radiat Oncol"},{"issue":"1","key":"2510_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/annonc\/mdv484","volume":"27","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonz\u00e1lez-Mart\u00edn A, Ledermann J, Marth C, Nout R, Querleu D, Mirza MR, Sessa C, the ESMO-ESGO-ESTRO Endometrial Consensus Conference Working Group. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27(1):16\u201341.","journal-title":"Ann Oncol"},{"key":"2510_CR11","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","volume":"19","author":"SM de Boer","year":"2018","unstructured":"de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Ottevanger PB, Ledermann JA, Khaw P, Colombo A, Fyles A, Baron M-H, J\u00fcrgenliemk-Schulz IM, Kitchener HC, Nijman HW, Wilson G, Brooks S, Carinelli S, Provencher D, Hanzen C, Lutgens LCHW, Smit VTHBM, Singh N, Do V, D\u2019Amico R, Nout RA, Feeney A, Verhoeven-Adema KW, Putter H, Creutzberg CL, on behalf of the PORTEC study group. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19:295\u2013309.","journal-title":"Lancet Oncol"},{"key":"2510_CR12","unstructured":"NCCN Clinical practice guidelines in oncology. Uterine neoplasms. Version 1. 2020."},{"issue":"1","key":"2510_CR13","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","volume":"16","author":"MM Harkenrider","year":"2017","unstructured":"Harkenrider MM, Block AM, Alektiar KM, Klopp A, Viswanathan AN, Small W Jr, et al. American brachytherapy task group report: adyuvant vaginal brachytherapy for early-stage endometrial cancer: a comprehensive review. Brachytherapy. 2017;16(1):95\u2013108.","journal-title":"Brachytherapy"},{"issue":"1","key":"2510_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","volume":"11","author":"W Small","year":"2012","unstructured":"Small W, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, Jones E, Rownd JJ, De Santos JFL, Viswanathan AN, Gaffney D. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy. 2012;11(1):58\u201367.","journal-title":"Brachytherapy"},{"issue":"2","key":"2510_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.brachy.2017.10.011","volume":"7","author":"JK Lee","year":"2018","unstructured":"Lee JK, Ghanem AI, Modh A, Burmeister C, Mahmoud O, Maxwell GL, Elshaikh MA. The impact of adjuvant vaginal brachytherapy in women with stage II uterine endometrioid carcinoma: results of a National Cancer Database analysis. Brachytherapy. 2018;7(2):319\u201325.","journal-title":"Brachytherapy"},{"key":"2510_CR16","volume-title":"Braquiterapia 3D guiada por la imagen","author":"AR Casino","year":"2017","unstructured":"Casino AR, Iracheta LA, Prat MA, Herreros A, Herruzo I, Casas AP, Rios MB, Marti SS. Cancer de endometrio postoperatorio. In: Casino AR, Ots PS, Iturre EV, editors. Braquiterapia 3D guiada por la imagen. Barcelona: EdikaMed SL; 2017. (ISBN: 978-84-7877-885-0)."},{"key":"2510_CR17","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ygyno.2018.07.020","volume":"151","author":"BG Wortman","year":"2018","unstructured":"Wortman BG, Bosse T, Nout RA, Lutgens LCHW, van der Steen-Banasik EM, Westerveld H, van den Berg H, Slot A, De Winter KAJ, Verhoeven-Adema KW, Smit VTHBM, Creutzberg CL, for the PORTEC Study Group. Molecular-integrated risk profile to determine adjuvant radiotherapy in endometrial cancer: evaluation of the pilot phase of the PORTEC4a trial. Gynecol Oncol. 2018;151:69\u201375.","journal-title":"Gynecol Oncol."},{"key":"2510_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.radonc.2015.06.016","volume":"116","author":"A Rovirosa","year":"2015","unstructured":"Rovirosa A, Ascaso C, Arenas M, Sabater S, Herreros A, Camarasa A, Rios I, Holub K, Pahisa J, Biete A. Can we shorten the overall treatment time in postoperative brachytherapy of endometrial carcinoma? Comparison of two brachytherapy schedules. Radiother Oncol. 2015;116:143\u20138.","journal-title":"Radiother Oncol"},{"issue":"1","key":"2510_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.brachy.2015.10.005","volume":"15","author":"S Sabater","year":"2016","unstructured":"Sabater S, Andres I, Jimenez-Jimenez E, Berenguer R, Sevillano M, Lopez-Honrubia V, Rovirosa A, Sanchez-Prieto R, Arenas M. Rectal contrast increases rectal dose during vaginal-cuff brachytherapy. Brachytherapy. 2016;15(1):35\u20139.","journal-title":"Brachytherapy"},{"key":"2510_CR20","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1200\/JCO.19.02381","volume":"38","author":"AR Yeung","year":"2020","unstructured":"Yeung AR, Pugh SL, Klopp AH, Gil KM, Wenzel L, Westin SN, Gaffney DK, et al. Improvement in patient-reported outcomes with intensity-modulated radiotherapy (RT) compared with standard RT: a report from the NRG oncology RTOG 1203 study. J Clin Oncol. 2020;38:1685\u201392.","journal-title":"J Clin Oncol."},{"key":"2510_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S0360-3016(00)00689-1","volume":"48","author":"S Nag","year":"2000","unstructured":"Nag S, Erickson B, Parikh S, et al. The American Brachytherapy Society Recommendations for HDR brachytherapy for carcinoma of the endometrium. Int J Radiat Oncol Biol Phys. 2000;48:779\u201390.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2510_CR22","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.ijrobp.2016.01.042","volume":"95","author":"CH Chapman","year":"2016","unstructured":"Chapman CH, Prisciandaro I, Maturen KE, et al. MRI-based evaluation of the vaginal cuff in brachytherapy planning: are we missing the target? Int J Radiat Oncol Biol Phys. 2016;95:743\u201350.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"2510_CR23","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.ijrobp.2016.04.010","volume":"95","author":"A Rovirosa","year":"2016","unstructured":"Rovirosa A, Herreros A. In regard to Chapman et al. Int J Radiat Oncol Biol Phys. 2016;95(4):1317\u20138.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2510_CR24","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.brachy.2017.07.003","volume":"16","author":"A Rovirosa","year":"2017","unstructured":"Rovirosa A, Herreros A, Camacho C, Ascaso C, Sanchez J, Cortes S, Sabater S, Sola J, Torne A, Arenas M. Comparative results of three short brachytherapy schedules as exclusive treatment in postoperative endometrial carcinoma. Brachytherapy. 2017;16:1169\u201374.","journal-title":"Brachytherapy"},{"issue":"8","key":"2510_CR25","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s12094-019-02255-z","volume":"22","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ascaso C, Herreros A, Sanchez J, Del Pino M, Torn\u00e9 A, Li Y, Sabater S, Arenas M, Biete A, Rovirosa A. Is one brachytherapy fraction of 7 Gy similar to more fractions after external beam irradiation in postoperative endometrial carcinoma? Clin Transl Oncol. 2020;22(8):1295\u2013302.","journal-title":"Clin Transl Oncol."},{"issue":"1","key":"2510_CR26","doi-asserted-by":"publisher","first-page":"40","DOI":"10.5114\/jcb.2018.74140","volume":"10","author":"MDV Aguilera","year":"2018","unstructured":"Aguilera MDV, Rovirosa \u00c1, Ascaso C, et al. Late G2 vagina toxicity in post-operative endometrial carcinoma is associated with a 68 Gy dose equivalentto 2 Gy per fraction (\u2329\/\u00ae=3Gy) at 2 cm3 of vagina. J Contemp Brachyther. 2018;10(1):40\u20136.","journal-title":"J Contemp Brachyther"},{"key":"2510_CR27","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.rpor.2020.01.002","volume":"25","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Ascaso C, Herreros A, S\u00e1nchez J, Sabater S, del Pino M, Li Y, G\u00f3mez G, Torn\u00e9 A, Biete A, Rovirosa \u00c1. Postoperative endometrial carcinoma treated with external beam irradiation plus vaginal-cuff brachytherapy. Is there a dose relationship with G2 vaginal complications? Rep Pract Oncol Radiother. 2020;25:227\u201332.","journal-title":"Rep Pract Oncol Radiother"},{"key":"2510_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ctro.2018.01.001","volume":"9","author":"R P\u00f6tter","year":"2018","unstructured":"P\u00f6tter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, Tan LT, Haie-Meder C, Mahantshetty U, Segedin B, Hoskin P, Bruheim K, Rai B, Huang F, Van Limbergen E, Schmid M, Nesvacil N, Sturdza A, Fokdal L, Jensen NBK, Georg D, Assenholt M, Seppenwoolde Y, Nomden C, Fortin I, Chopra S, van der Heide U, Rumpold T, Lindegaard JC, J\u00fcrgenliemk-Schulz I, the EMBRACE Collaborative Group. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48\u201360.","journal-title":"Clin Transl Radiat Oncol"},{"issue":"1","key":"2510_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.brachy.2019.09.004","volume":"19","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Rovirosa A, Ascaso C, Herreros A, Torne A, Li Y, Biete A, S\u00e1nchez J. Economic impact of decreasing the fraction number in vaginal cuff brachytherapy: a direct cost analysis. Brachytherapy. 2020;19(1):60\u20135.","journal-title":"Brachytherapy."}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-020-02510-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02510-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T12:40:59Z","timestamp":1619700059000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-020-02510-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["2510"],"URL":"https:\/\/doi.org\/10.1007\/s12094-020-02510-8","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"type":"print","value":"1699-048X"},{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2020,11,25]]},"assertion":[{"value":"31 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There is no Conflict of Ethics and Consent Statements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animal performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"For this type of study formal consent is not required.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}